X

Market News

Earnings: Celsion Q2 loss narrows on lower expenses

Oncology drug development company Celsion Corporation (NASDAQ: CLSN) Thursday reported a narrower net loss for the second quarter of 2019,…

Bio-Path’s loss expands in Q2

Biotech company Bio-Path Holdings (NASDAQ: BPTH) reported a loss of $2.5 million or $0.87 per share for the second quarter…

JCPenney reports 9% decline in comparable sales in Q2

J.C. Penney Company Inc. (NYSE: JCP) surpassed market estimates on bottom-line for the second quarter of 2019 but reported lower-than-expected…

WeWork files to go public, revenue as well as loss doubles in 2018

After a flurry of tech company IPOs in the first half of 2019, here’s another company that filed its IPO…

Arcadia Biosciences swings to profit in Q2

Arcadia Biosciences (NASDAQ: RKDA) swung to profit in the second quarter from a loss last year, helped by the change…

Baidu likely to report weak Q2 earnings on Aug 19

Baidu Inc. (NASDAQ: BIDU) is set to release its second-quarter earnings results on Monday, August 19 after the market closes.…

Canada Goose posts wider losses despite higher revenues in Q1

Canada Goose Holdings Inc. (NYSE: GOOS) on Wednesday reported a wider-than-expected loss on revenues that were higher than the street consensus…

Bio-Path likely to report wider Q2 loss on Aug. 15

Bio-Path Holdings (NASDAQ: BPTH) is expected to continue incurring significant operating losses in the second quarter. Also, the losses are…

CorMedix narrows loss in Q2, revenue miss estimates

CorMedix (NYSE: CRMD) reported mixed second quarter results after the bell. Revenue failed to beat estimates, while earnings came in…

Earnings preview: Will losses continue for Celsion in Q2

Celsion Corporation (NASDAQ: CLSN) is set to release its earnings results for the second quarter on Thursday before the market…